First tazarotene lotion treatment for acne vulgaris, ARAZLO , now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plans Pharmaceutical Investing
Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer Life Science Investing
Gilead Sciences: Tatiana Williams Leads the Way With the Transinclusive Group Pharmaceutical Investing
Abbott's FreeStyle Libre® 3 Integrated with Automated Insulin Delivery System mylife Loop in Germany Pharmaceutical Investing
LYNPARZA® in Combination With Abiraterone and Prednisone or Prednisolone Approved in the EU as Treatment for Certain Patients With Metastatic Castration-Resistant Prostate Cancer Life Science Investing
Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis Life Science Investing
Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts Life Science Investing
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer Pharmaceutical Investing
Astellas, Seagen and Merck Announce FDA Acceptance of Supplemental Biologics License Applications for PADCEV® with KEYTRUDA® for the First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer Life Science Investing
Seagen, Astellas and Merck Announce FDA Acceptance of sBLAs for PADCEV® with KEYTRUDA® for the First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer Life Science Investing
